Doctor profile · Federal record
Dr. CHAO YIN, MD
Hematology & Oncology Physician (CMS: HEMATOLOGY/ONCOLOGY) · Internal Medicine Physician · FAIRFAX, VA
- NPI 1477909240
- Accepts Medicare
- MIPS 89.8 / 100 · 2023
- 10 yrs in practice
- Male
- Solo practice
- No sanctions
Practice & contact
- Primary practice
-
8613 ROUTE 29 # 200N
FAIRFAX, VA 220312171
(571) 350-8400
fax (703) 280-9596 - Mailing address
-
3040 WILLIAMS DR STE 100
FAIRFAX, VA 220314618
Credentials & registration
- NPI registered
- May 2016 — 10 yrs on file
- Profile last updated
- April 24, 2024
- Year of graduation
- 2016 — 10 yrs since
- Specialty taxonomy
- 207RH0003X — NUCC code
- State license (1)
- Virginia #0101265952
- Medicaid
- VA #1477909240
Federal sanctions & exclusions
No sanctions, exclusions or revocations on file
Checked against OIG LEIE on NPI 1477909240. Last verified May 11, 2026.Medicare procedures · 2023
Top services delivered
Total services
96,138
Distinct HCPCS
10
Medicare allowed
$1,461,666
| HCPCS | Description | Services | Patients | Avg allowed | |
|---|---|---|---|---|---|
J1439 |
Injection, ferric carboxymaltose, 1 mg | 27,000 | 30 | $1 | |
J0881 |
Injection, darbepoetin alfa, 1 microgram (non-esrd use) | 15,260 | 37 | $3 | |
J9144 |
Injection, daratumumab, 10 mg and hyaluronidase-fihj | 14,040 | 31 | $47 | |
J9025 |
Injection, azacitidine, 1 mg | 8,100 | 11 | $0 | |
J9267 |
Injection, paclitaxel, 1 mg | 6,690 | 20 | $0 | |
J9271 |
Injection, pembrolizumab, 1 mg | 6,500 | 12 | $54 | |
J9263 |
Injection, oxaliplatin, 0.5 mg | 5,710 | 11 | $0 | |
Q5119 |
Injection, rituximab-pvvr, biosimilar, (ruxience), 10 mg | 1,570 | 17 | $28 | |
J1100 |
Injection, dexamethasone sodium phosphate, 1 mg | 1,460 | 79 | $0 | |
J0185 |
Injection, aprepitant, 1 mg | 1,430 | 11 | $2 |
In context: peer comparison
Among 7 peers in this city , average services per provider: 1,248. This provider delivers 77× the peer median.Open Payments
Industry payments received
All-time total
$2,304
Transactions
59
Manufacturers
15
| Payer (manufacturer) | Industry | Txns | Amount |
|---|---|---|---|
| AstraZeneca Pharmaceuticals LP | 3 | $554.68 | |
| Janssen Biotech, Inc. | 9 | $268.28 | |
| Novartis Pharmaceuticals Corporation | 9 | $199.46 | |
| Daiichi Sankyo Inc. | 12 | $157.98 | |
| Myriad Genetic Laboratories, Inc. | 1 | $130.04 | |
| ABBVIE INC. | 4 | $118.55 | |
| Gilead Sciences, Inc. | 3 | $79.61 | |
| Celgene Corporation | 3 | $69.42 | |
| Takeda Pharmaceuticals U.S.A., Inc. | 3 | $63.75 | |
| Genentech USA, Inc. | 2 | $56.16 | |
| Alexion Pharmaceuticals, Inc. | 2 | $48.02 | |
| Eisai Inc. | 2 | $47.51 | |
| PFIZER INC. | 3 | $47.36 | |
| BIOPROTECT MEDICAL, INC. | 1 | $45.50 | |
| SERVIER PHARMACEUTICALS LLC | 2 | $45.03 |
By nature of payment
Medicare Part D · 2023
Top prescriptions
Total claims
284
Patients
28
Total drug cost
$548,010
| Drug | Type | Claims | Patients | Total cost |
|---|---|---|---|---|
| Eliquis (Apixaban) | Brand | 48 | 12 | $32,583 |
| Dexamethasone | Generic | 40 | 16 | $807 |
| Xarelto (Rivaroxaban) | Brand | 36 | 0 | $20,731 |
| Lenalidomide | Generic | 23 | 0 | $253,355 |
| Acyclovir | Generic | 20 | 0 | $420 |
| Anastrozole | Generic | 17 | 0 | $940 |
| Ibrance (Palbociclib) | Brand | 14 | 0 | $237,476 |
| Levofloxacin | Generic | 14 | 0 | $853 |
| Prednisone | Generic | 14 | 0 | $61 |
| Lidocaine-Prilocaine (Lidocaine/Prilocaine) | Brand | 12 | 0 | $290 |